Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein

Cited by (429)

Items 101–200 of 429

  1. Deep mutational scanning reveals the structural basis for α-synuclein activity
    Robert W. Newberry, Jaime T. Leong, Eric D. Chow, Martin Kampmann, William F. DeGrado · 2020 · Nature Chemical Biology
  2. Hypokinesia and Reduced Dopamine Levels in Zebrafish Lacking β- and γ1-Synucleins
    Chiara Milanese, Jonathan J. Sager, Qing Bai, Thomas C. Farrell, Jason R. Cannon, J. Timothy Greenamyre, Edward A. Burton · 2011 · Journal of Biological Chemistry
  3. Genetics of Parkinson’s disease and related disorders
    Pei-Lan Zhang, Yan Chen, Chen-Hao Zhang, Yuxin Wang, Pedro Fernández-Fúnez · 2017 · Journal of Medical Genetics
  4. Identification of ubiquitin‐interacting proteins in purified polyglutamine aggregates
    Hiroshi Doi, Kenichi Mitsui, Masaru Kurosawa, Yoko Machida, Yoshiyuki Kuroiwa, Nobuyuki Nukina · 2004 · FEBS Letters
  5. Cellular Strategies for Regulating Functional and Nonfunctional Protein Aggregation
    Jörg A. Gsponer, M. Madan Babu · 2012 · Cell Reports
  6. Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease
    Sian E. W. Davies, Penelope J. Hallett, Thomas G. Moens, Gaynor Ann Smith, Emily N. Mangano, Hyoung Tae Kim, Alfred Lewis Goldberg, Ji‐Long Liu, Ole Isacson A, George K. Tofaris · 2014 · Neurobiology of Disease
  7. Using human neural stem cells to model neurological disease
    Rebekah J. Jakel, Bernard Laurent Schneider, Clive N. Svendsen · 2004 · Nature Reviews Genetics
  8. The Influence of Vesicle Size and Composition on α-Synuclein Structure and Stability
    Lars Kjær, Lise Giehm, Thomas Heimburg, Daniel E. Otzen · 2009 · Biophysical Journal
  9. Off-Target Effects of Psychoactive Drugs Revealed by Genome-Wide Assays in Yeast
    Ericson, Elke, Gebbia, Marinella, Heisler, Lawrence E., Wildenhain, Jan, Tyers, Mike, Giaever, Guri, Nislow, Corey · 2008 · PLoS Genetics
  10. Amyloid in neurodegenerative diseases: Friend or foe?
    Katie J. Wolfe, Douglas Cyr · 2011 · Seminars in Cell and Developmental Biology
  11. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration
    Sandra Tenreiro, Matthias Christoph Munder, Simon Alberti, Tiago F. Outeiro · 2013 · Journal of Neurochemistry
  12. A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potential
    Gerard Griffioen, Hein Duhamel, Nele Van Damme, Klaartje Pellens, Piotr Zabrocki, Christophe C. Pannecouque, Fred VAN LEUVEN, Joris Winderickx, Stefaan Wera · 2005 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  13. Modulation of Aβ42low-n oligomerization using a novel yeast reporter system
    Sviatoslav N. Bagriantsev, Susan Weiss Liebman · 2006 · BMC Biology
  14. Yeast as a Touchstone in Post-genomic Research: Strategies for Integrative Analysis in Functional Genomics
    Juan Ignacio Castrillo, Stephen G. Oliver · 2004 · BMB Reports
  15. Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT
    Naoki Hayashida, Mitsuaki Fujimoto, Ke Tan, Ramachandran Prakasam, Toyohide Shinkawa, Liangping Li, Hitoshi Ichikawa, Ryosuke Takii, Akira Nakai · 2010 · The EMBO Journal
  16. Genetic and Environmental Factors Influencing Glutathione Homeostasis inSaccharomyces cerevisiae
    Gabriel G. Perrone, Chris M. Grant, Ian W. Dawes · 2004 · Molecular Biology of the Cell
  17. Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
    John Steele, Shulin Ju, Martin Lenard Lachenmayer, J. Liken, Aryeh Stock, Soo Yeon Kim, Luz M. Delgado, Iván E. Alfaro, Sebastián Bernales, Giuseppe Verdile et al. · 2012 · Molecular Psychiatry
  18. Yeast toxicogenomics: genome-wide responses to chemical stresses with impact in environmental health, pharmacology, and biotechnology
    Sandra Costa dos Santos · 2012 · Frontiers in Genetics
  19. Neurodegenerative diseases: Lessons from genome‐wide screens in small model organisms
    Tjakko J. van Ham, Rainer Breitling, Morris A. Swertz, Ellen A. A. Nollen · 2009 · EMBO Molecular Medicine
  20. α-Synuclein Alters Proteasome Function, Protein Synthesis, and Stationary Phase Viability
    Qinghua Chen, Jeffery A. Thorpe, Jeffrey N. Keller · 2005 · Journal of Biological Chemistry
  21. Glutathione S-Transferase Omega 1 Activity Is Sufficient to Suppress Neurodegeneration in a Drosophila Model of Parkinson Disease
    Kiyoung Kim, Song‐Hee Kim, Jaekwang Kim, Heuijong Kim, Jeongbin Yim · 2012 · Journal of Biological Chemistry
  22. A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity
    Fabien D’Angelo, Hélène Vignaud, Julie S. Di Martino, Bénédicte Salin, Anne Devin, Christophe Cullin, Christelle Marchal · 2012 · Disease Models & Mechanisms
  23. Protein Quality Control in Neurodegenerative Disease
    Jason E. Gestwicki, Dan Garza · 2012 · Progress in molecular biology and translational science
  24. α-Synuclein Budding Yeast Model: Toxicity Enhanced by Impaired Proteasome and Oxidative Stress
    Nijee Sharma, Katrina A. Brandis, Sara Herrera, Brandon E. Johnson, Tulaza Vaidya, Ruja Shrestha, Shubhik K. DebBurman · 2006 · Journal of Molecular Neuroscience
  25. Spatial sequestration and detoxification of Huntingtin by the ribosome quality control complex
    Junsheng Yang, Xinxin Hao, Xiuling Cao, Beidong Liu, Thomas Nyström · 2016 · eLife
  26. FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism
    Xin Chen, Boyang Ji, Xinxin Hao, Xiaowei Li, Frederik Eisele, Thomas Nyström, Dina Petranović · 2020 · Nature Communications
  27. Aggregation of α-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis
    James H. Soper, Victoria M. Kehm, Christopher G. Burd, Vytas A. Bankaitis, Virginia M.‐Y. Lee · 2010 · Journal of Molecular Neuroscience
  28. High and stable ATP levels prevent aberrant intracellular protein aggregation in yeast
    Masak Takaine, Hiromi Imamura, Satoshi Yoshida · 2022 · eLife
  29. The Ubiquitin-Proteasome Pathway in Huntington's Disease
    Siddhartha S. Mitra, Steven M. Finkbeiner · 2008 · The Scientific World JOURNAL
  30. Determining crystal structures through crowdsourcing and coursework
    Horowitz, Scott, Koepnick, Brian, Martin, Raoul, Tymieniecki, Agnes, Winburn, Amanda A., Cooper, Seth, Flatten, Jeff, Rogawski, David S., Koropatkin, Nicole M., Hailu, Tsinatkeab T. et al. · 2016 · Nature Communications
  31. Hsp70 molecular chaperones and Parkinson's disease
    Stephan N. Witt · 2009 · Biopolymers
  32. Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
    Valerio Chiurchiù, Marta Tiberi, Alessandro Matteocci, Federico Fazio, Hasibullah Siffeti, Stefano Saracini, Nicola Biagio Mercuri, Giuseppe Sancesario · 2022 · International Journal of Molecular Sciences
  33. Approaches to study yeast cell aging and death
    Mario G. Mirisola, Ralf J. Braun, Dina Petranović · 2013 · FEMS Yeast Research
  34. α-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles
    Jobin Varkey, Naoko Mizuno, Balachandra Gajanan Hegde, Naiqian Cheng, Alasdair C. Steven, Ralf Langen · 2013 · Journal of Biological Chemistry
  35. Nervous yeast: modeling neurotoxic cell death
    Ralf J. Braun, Sabrina Büttner, Julia Ring, Guido Kroemer, Frank Madeo · 2009 · Trends in Biochemical Sciences
  36. The stationary phase model of aging in yeast for the study of oxidative stress and age-related neurodegeneration
    Quinghua Chen, Qunxing Ding, Jeffrey N. Keller · 2005 · Biogerontology
  37. Prospects of yeast systems biology for human health: integrating lipid, protein and energy metabolism
    Dina Petranović, Keith E. J. Tyo, Goutham N. Vemuri, Jens Nielsen · 2010 · FEMS Yeast Research
  38. Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies
    Laura Pieri, Philippe Chafey, Morgane Le Gall, Guilhem Clary, Ronald Melki, Virginie Redeker · 2015 · Biochimica et Biophysica Acta (BBA) - General Subjects
  39. alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson’s disease pathology
    Sibylle E. Eisbach, Tiago F. Outeiro · 2013 · Journal of Molecular Medicine
  40. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease
    Tessa Sinnige, Anan Yu, Richard I. Morimoto · 2020 · Advances in experimental medicine and biology
  41. Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington’s disease
    Rebecca Aron, Pasquale Pellegrini, Edward W. Green, Daniel C. Maddison, Kwadwo Opoku-Nsiah, Ana Osório Oliveira, Jinny S. Wong, Aaron C. Daub, Flaviano Giorgini, Paul J. Muchowski et al. · 2018 · Nature Communications
  42. Augmenting brain metabolism to increase macro- and chaperone-mediated autophagy for decreasing neuronal proteotoxicity and aging
    Ben Loos, Daniel J. Klionsky, Esther S.P. Wong · 2017 · Progress in Neurobiology
  43. Oxidative stress and aging: Learning from yeast lessons
    Elis C. A. Eleuthério, Aline de Araújo Brasil, Mauro Braga França, Diego S. G. de Almeida, Germana Breves Rona, Rayne Stfhany Silva Magalhães · 2017 · Fungal Biology
  44. Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context
    Vicente Sancenón, Sue-Ann Lee, Christina Patrick, Janice M. Griffith, Amy Paulino, Tiago F. Outeiro, Fulvio Reggiori, Eliezer Masliah, Paul J. Muchowski · 2012 · Human Molecular Genetics
  45. Protein Carbonyl and the Methionine Sulfoxide Reductase System
    Jackob Moskovitz, Derek B. Oien · 2009 · Antioxidants and Redox Signaling
  46. Inhibition of lysosomal functions reduces proteasomal activity
    Liyan Qiao, Jianhua Zhang · 2009 · Neuroscience Letters
  47. Proteostasis of Huntingtin in Health and Disease
    Seda Koyuncu, Azra Fatima, Ricardo Gutiérrez-García, David Vı́lchez · 2017 · International Journal of Molecular Sciences
  48. The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis
    Giulia Cazzanelli, Flávia Dayana Silva Pereira, Sara Alves, Rita Francisco, Luı́sa Azevedo, Patrícia Dias Carvalho, Ana F. Almeida, Manuela Côrte‐Real, María José Oliveira, Cândida Lucas et al. · 2018 · Cells
  49. From the baker to the bedside: yeast models of Parkinson's disease
    Regina Menezes, Sandra Tenreiro, Diana Macedo, Cláudia Nunes dos Santos, Tiago F. Outeiro · 2015 · Microbial Cell
  50. Synphilin-1 Enhances α-Synuclein Aggregation in Yeast and Contributes to Cellular Stress and Cell Death in a Sir2-Dependent Manner
    Sabrina Büttner, Charlotte Delay, Vanessa Franssens, Tine Bammens, Doris Ruli, Sandra Zaunschirm, Rita Machado de Oliveira, Tiago F. Outeiro, Frank Madeo, Luc Buée et al. · 2010 · PLoS ONE
  51. α-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease
    Stephan N. Witt, Todd R. Flower · 2006 · FEMS Yeast Research
  52. Contribution of Yeast Models to Neurodegeneration Research
    Clara Pereira, Cláudia Bessa, Joana Soares, Mariana Leão, Lucı́lia Saraiva · 2012 · BioMed Research International
  53. Yeast models of Parkinson’s disease-associated molecular pathologies
    Sandra Tenreiro, Vanessa Franssens, Joris Winderickx, Tiago F. Outeiro · 2017 · Current Opinion in Genetics & Development
  54. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases
    Tiago F. Outeiro, Flaviano Giorgini · 2006 · Biotechnology Journal
  55. Modeling Huntington disease in yeast: Perspectives and future directions
    Robert P. Mason, Flaviano Giorgini · 2011 · Prion
  56. Novel suppressors of α-synuclein toxicity identified using yeast
    Jun Liang, Cheryl Clark-Dixon, Shaoxiao Wang, Todd R. Flower, Tara Williams-Hart, Richard M. Zweig, Lucy C. Robinson, Kelly Tatchell, Stephan N. Witt · 2008 · Human Molecular Genetics
  57. Polyglutamine gene function and dysfunction in the ageing brain
    Sarah L. Hands, Christopher Sinadinos, Andreas Wyttenbach · 2008 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  58. Disease-Modifying Pathways in Neurodegeneration
    Steven M. Finkbeiner, Ana María Cuervo, Richard I. Morimoto, Paul J. Muchowski · 2006 · Journal of Neuroscience
  59. Yeast unfolds the road map toward α-synuclein-induced cell death
    Vanessa Franssens, E Boelen, Jayamani Anandhakumar, Thomas Vanhelmont, Sabrina Büttner, Joris Winderickx · 2009 · Cell Death and Differentiation
  60. Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome
    Leslie Ripaud, Victoria Chumakova, Matthias Antonin, Alex R. Hastie, Stefan Pinkert, Roman Körner, Kiersten M. Ruff, Rohit V. Pappu, Daniel Hornburg, Matthias Mann et al. · 2014 · Proceedings of the National Academy of Sciences
  61. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity
    Marc Brehme, Cindy Voisine · 2016 · Disease Models & Mechanisms
  62. A Novel Mechanism of Interaction between α-Synuclein and Biological Membranes
    Yoon Suk Kim, Emmanuelle Laurine, Wendy S. Woods, Seung‐Jae Lee · 2006 · Journal of Molecular Biology
  63. Potential therapeutic effects of polyphenols in Parkinson’s disease: in vivo and in vitro pre-clinical studies
    Claudio Giuliano, Silvia Cerri, Fabio Blandini · 2020 · Neural Regeneration Research
  64. Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator
    João Tiago S. Fernandes, Sandra Tenreiro, Andreia Gameiro, Virginia Chu, Tiago F. Outeiro, João Pedro Conde · 2014 · Lab on a Chip
  65. Defects in Very Long Chain Fatty Acid Synthesis Enhance Alpha-Synuclein Toxicity in a Yeast Model of Parkinson's Disease
    Yong Joo Lee, Shaoxiao Wang, Sunny R. Slone, Talene A. Yacoubian, Stephan N. Witt · 2011 · PLoS ONE
  66. Biological factors and statistical limitations prevent detection of most noncanonical proteins by mass spectrometry
    Aaron C. Wacholder, Anne‐Ruxandra Carvunis · 2023 · PLoS Biology
  67. Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity
    Eran Tauber, Leonor Miller‐Fleming, Robert P. Mason, Wanda Kwan, Jannine Clapp, Nicola J. Butler, Tiago F. Outeiro, Paul J. Muchowski, Flaviano Giorgini · 2010 · Journal of Biological Chemistry
  68. Protein stability and aggregation in Parkinson's disease
    Philip Alan Robinson · 2008 · Biochemical Journal
  69. Inhibition of formation of α-synuclein inclusions by mannosylglycerate in a yeast model of Parkinson's disease
    Cristiana Faria, Carla D. Jorge, Nuno Borges, Sandra Tenreiro, Tiago F. Outeiro, Helena Santos · 2013 · Biochimica et Biophysica Acta (BBA) - General Subjects
  70. Dealing with Misfolded Proteins: Examining the Neuroprotective Role of Molecular Chaperones in Neurodegeneration
    Yousuf Ali, Brandon M. Kitay, Rong Grace Zhai · 2010 · Molecules
  71. Beer and Bread to Brains and Beyond: Can Yeast Cells Teach Us about Neurodegenerative Disease?
    Aaron D. Gitler · 2007 · Neurosignals
  72. Suppression of polyglutamine‐induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis
    Alejandro Ocampo, Andrea Zambrano, Antoni Barrientos · 2009 · The FASEB Journal
  73. Membranes as modulators of amyloid protein misfolding and target of toxicity
    Anoop Rawat, Ralf Langen, Jobin Varkey · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  74. TDP-43 toxicity in yeast
    Maria Armakola, Michael P. Hart, Aaron D. Gitler · 2010 · Methods
  75. Genetic modifiers of neurological disease
    Jennifer A. Kearney · 2011 · Current Opinion in Genetics & Development
  76. Parkinson's disease, proteins, and prions: Milestones
    C. Warren Olanow, K. St. P. McNaught · 2011 · Movement Disorders
  77. Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
    Elisa Greggio, Marco Bisaglia, Laura Civiero, Luigi Bubacco · 2011 · Molecular Neurodegeneration
  78. Mitochondrion-mediated cell death: dissecting yeast apoptosis for a better understanding of neurodegeneration
    Ralf J. Braun · 2012 · Frontiers in Oncology
  79. Molecular Genetics Approaches in Yeast to Study Amyloid Diseases
    Tiago F. Outeiro, Paul J. Muchowski · 2004 · Journal of Molecular Neuroscience
  80. Protein aggregation into insoluble deposits protects from oxidative stress
    Anita Čarija, Susanna Navarro, Natalia Sánchez de Groot, Salvador Ventura · 2017 · Redox Biology
  81. The Benefits of Humanized Yeast Models to Study Parkinson’s Disease
    Vanessa Franssens, Tine Bynens, Jeff Van den Brande, Katrien Vandermeeren, Mathias Verduyckt, Joris Winderickx · 2013 · Oxidative Medicine and Cellular Longevity
  82. Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches
    Sebastian J. Hofer, Katharina Kainz, Andreas Zimmermann, Maria Anna Bauer, Tobias Pendl, Michael Poglitsch, Frank Madeo, Didac Carmona‐Gutiérrez · 2018 · Frontiers in Molecular Neuroscience
  83. A Toolkit for Precise, Multigene Control in Saccharomyces cerevisiae
    Adam Sanford, Szilvia Kiriakov, Ahmad S. Khalil · 2022 · ACS Synthetic Biology
  84. Identification of genes that enhance cellulase protein production in yeast
    Takao Kitagawa, Katsunori Kohda, Kenro Tokuhiro, Hisashi Hoshida, Rinji Akada, Haruo Takahashi, Takao Imaeda · 2010 · Journal of Biotechnology
  85. Use of Yeast as a Model System to Investigate Protein Conformational Diseases
    Christina M. Coughlan, Jeffrey L. Brodsky · 2005 · Molecular Biotechnology
  86. Identification and Microbial Production of the Raspberry Phenol Salidroside that Is Active against Huntington’s Disease
    Nicolai Kallscheuer, Regina Menezes, Alexandre Foito, Marcelo Henriques da Silva, Adelaide Braga, Wijbrand J. C. Dekker, David Méndez Sevillano, Rita Rosado-Ramos, Carolina Jardim, Joana Oliveira et al. · 2018 · PLANT PHYSIOLOGY
  87. Application of yeast to studying amyloid and prion diseases
    Yury O. Chernoff, Anastasia V. Grizel, Aleksandr A. Rubel, Andrew А. Zelinsky, Pavithra Chandramowlishwaran, Tatiana Alexandrovna Chernova · 2020 · Advances in genetics
  88. Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process
    Chai-jui Tsai, Kiran Aslam, Holli M. Drendel, Josephat M. Asiago, Kourtney M. Goode, Lake N. Paul, Jean‐Christophe Rochet, Tony R. Hazbun · 2015 · Journal of Biological Chemistry
  89. Connecting the dots in Huntington's disease with protein interaction networks.
    Flaviano Giorgini, Paul J. Muchowski · 2005 · Genome biology
  90. Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease.
    Hakimeh Zali, Mona Zamanian Azodi, Mostafa Rezaei–Tavirani, Alireza Akbarzadeh Baghban · 2015 · Europe PMC (PubMed Central)
  91. α-Synuclein Fission Yeast Model: Concentration-Dependent Aggregation Without Plasma Membrane Localization or Toxicity
    Katrina A. Brandis, Isaac F. Holmes, Samantha J. England, Nijee Sharma, Lokesh Kukreja, Shubhik K. DebBurman · 2006 · Journal of Molecular Neuroscience
  92. The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
    Kristina Battis, Wei Xiang, Jürgen Winkler · 2023 · International Journal of Molecular Sciences
  93. Studying Spatial Protein Quality Control, Proteopathies, and Aging Using Different Model Misfolding Proteins in S. cerevisiae
    Kara L. Schneider, Thomas Nyström, Per O. Widlund · 2018 · Frontiers in Molecular Neuroscience
  94. Curcumin Prevents Formation of Polyglutamine Aggregates by Inhibiting Vps36, a Component of the ESCRT-II Complex
    Meenakshi Verma, Abhishek A. Sharma, Swarna Naidu, Ankan Kumar Bhadra, Ritushree Kukreti, Vibha Taneja · 2012 · PLoS ONE
  95. Clearance and Phosphorylation of Alpha-Synuclein Are Inhibited in Methionine Sulfoxide Reductase A Null Yeast Cells
    Derek B. Oien, Heather E. Shinogle, David S. Moore, Jackob Moskovitz · 2009 · Journal of Molecular Neuroscience
  96. Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity
    Sandra Tenreiro, Rita Rosado-Ramos, Ellen Gerhardt, Filippo Favretto, Filipa Magalhães, Bilyana Popova, Stefan Becker, Markus Zweckstetter, Gerhard H. Braus, Tiago F. Outeiro · 2015 · Human Molecular Genetics
  97. Yeast buddies helping to unravel the complexity of neurodegenerative disorders
    Gernot Fruhmann, David Seynnaeve, Ju Zheng, Karen Ven, Sofie Molenberghs, Tobias Wilms, Beidong Liu, Joris Winderickx, Vanessa Franssens · 2016 · Mechanisms of Ageing and Development
  98. Yeast genetics targets lipids in Parkinson's disease
    Clemens R. Scherzer, Mel Β. Feany · 2004 · Trends in Genetics
  99. Aggregation of PolyQ Proteins Is Increased upon Yeast Aging and Affected by Sir2 and Hsf1: Novel Quantitative Biochemical and Microscopic Assays
    Aviv Cohen, Liron Ross, Iftach Nachman, Shoshana Bar‐Nun · 2012 · PLoS ONE
  100. Identification of Human Proteins That Modify Misfolding and Proteotoxicity of Pathogenic Ataxin-1
    Spyros Petrakis, Tamás Raskó, Jenny Russ, Ralf P. Friedrich, Martin Strödicke, Sean‐Patrick Riechers, Katja Muehlenberg, Angeli Möller, Anita Reinhardt, Arunachalam Vinayagam et al. · 2012 · PLoS Genetics